Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

AGEN

Agenus (AGEN)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AGEN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next >>

Date	Time	Source	Headline	Symbol	Company
06/16/2021	5:20PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGEN	Agenus Inc
06/15/2021	8:30AM	GlobeNewswire Inc.	Agenus Announces Virtual Annual Shareholders Meeting	NASDAQ:AGEN	Agenus Inc
06/07/2021	7:54PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
06/04/2021	9:09AM	GlobeNewswire Inc.	Agenus’ Presentations at ASCO 2021 Demonstrate Differentiated Activity of Balstilimab and Provide Clinical Update on AGEN23...	NASDAQ:AGEN	Agenus Inc
06/01/2021	4:05PM	GlobeNewswire Inc.	Agenus to Participate in Fireside Chat at the Jefferies 2021 Virtual Healthcare Conference	NASDAQ:AGEN	Agenus Inc
05/21/2021	6:14PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
05/20/2021	7:00AM	GlobeNewswire Inc.	Agenus Presents New Data on Balstilimab and AGEN2373 in ASCO Abstracts	NASDAQ:AGEN	Agenus Inc
05/19/2021	4:32PM	TipRanks	Is Agenus Stock Still Worth Buying After Its 20%-Plus Rally? Analyst Weighs In	NASDAQ:AGEN	Agenus Inc
05/18/2021	7:41AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGEN	Agenus Inc
05/18/2021	7:31AM	GlobeNewswire Inc.	Agenus to Host Conference Call to Discuss Global Licensing Agreement with Bristol Myers Squibb for Agenus’ Anti-TIGIT Bispe...	NASDAQ:AGEN	Agenus Inc
05/18/2021	7:30AM	GlobeNewswire Inc.	Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific Antibody Program	NASDAQ:AGEN	Agenus Inc
05/18/2021	7:30AM	Business Wire	Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific Antibody Program	NASDAQ:AGEN	Agenus Inc
05/10/2021	5:07PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:AGEN	Agenus Inc
05/07/2021	6:06PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
05/07/2021	4:13PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AGEN	Agenus Inc
05/06/2021	7:45AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGEN	Agenus Inc
05/06/2021	7:45AM	GlobeNewswire Inc.	Agenus Corporate Update and First Quarter 2021 Financial Report	NASDAQ:AGEN	Agenus Inc
04/30/2021	4:04PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:AGEN	Agenus Inc
04/28/2021	5:30PM	GlobeNewswire Inc.	Agenus to Present at the 2021 ASCO Annual Meeting	NASDAQ:AGEN	Agenus Inc
04/23/2021	6:35PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
04/22/2021	4:05PM	GlobeNewswire Inc.	Agenus to Provide Corporate Update and First Quarter 2021 Financial Report	NASDAQ:AGEN	Agenus Inc
04/19/2021	8:30AM	GlobeNewswire Inc.	Agenus Submits Balstilimab Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical C...	NASDAQ:AGEN	Agenus Inc
04/14/2021	8:30AM	GlobeNewswire Inc.	Agenus Doses First Cancer Patient with iNKT Cell Therapy	NASDAQ:AGEN	Agenus Inc
04/10/2021	8:35AM	GlobeNewswire Inc.	New Clinical Responses for AGEN1181 Presented at AACR	NASDAQ:AGEN	Agenus Inc
04/09/2021	5:07PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
04/06/2021	8:30AM	GlobeNewswire Inc.	Agenus to Participate in Webcast Hosted by William Blair on AGEN1181 and Balstilimab AACR Presentations	NASDAQ:AGEN	Agenus Inc
04/05/2021	6:56PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
04/05/2021	6:40PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
04/05/2021	6:22PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
04/05/2021	6:05PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc

Showing the most relevant articles for your search:NASDAQ:AGEN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next >>

Marketing Worldwide (PK)

Bell Buckle (PK)

Seafarer Exploration (PK)

Canopus Biopharma (PK)

NioCorp Developments

Brookmount Explorations (PK)

Therapeutic Solutions (PK)

Seven Arts Entertainment (PK)

Virexit Technologies (PK)

Fannie Mae (QB)

Decentral Life (PK)

Ubiquitech Software (PK)

Kraig Biocraft Laborator... (QB)

Delayed Upgrade Clock